PATENT CLAIM ANALYSIS

Application Number: 15566418
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "210000"]

Abstract:
Compounds of formula I are provided. Also provided are methods of preparing the compounds of formula (I), and methods of using the compounds of formula (I) as a negative allosteric modulator of a metabotropic glutamate receptor (mGluR) subtype 5.

Claim (Index 13):
A method of treating a disease associated with metabotropic glutamate receptor subtype 5 (mGluR5) in a subject, the method comprising administering to the subject the pharmaceutical composition of  claim 7 .

Metadata:
- Claim Count in Document: 22.0
- Percentile: 88.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14344957', '12908588', '15771920', '12912124', '13542234']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7981025017086095
- 35 USC 102 Novelty (BERT): 0.5282361789099328
- Combined Prediction Score: 0.7711158694287419
- Mean Citation Score: 333.88199999999995
- Max Citation Score: 349.1565
- Similarity Product: 279.39205021575094

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test